Co-trimoxazole in addition to antiretroviral therapy may reduce malaria risk in HIV positive adultsBMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i49 (Published 06 January 2016) Cite this as: BMJ 2016;352:i49
- Nigel Hawkes
In malaria endemic regions people with HIV infection who are treated with antiretroviral therapy do better if they are also given the antibiotic co-trimoxazole, a trial in Kenya has shown.1
Prophylactic use of co-trimoxazole has been recommended by the World Health Organization since 2006, but that guidance predated the widespread use of antiretroviral therapy, so it has not been clear whether it remained appropriate. The trial, by showing that mortality and morbidity were higher among those in whom …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial